Talks to sell the British pharmacy chain Boots to the Anglo Canadian Weston family have stalled after the Westons cut their offer, a reduction Boots' current ownership has rejected, leaving what one source close to the talks described as a roughly even chance the deal survives at all. The Westons revised their bid downward after Australia's Sigma Healthcare walked away from a rival offer in June, leaving the family as the only remaining suitor and, apparently, less inclined to pay a premium for a deal with no competing bidder left to worry about.
The obstacle holding up a resolution is not really a pricing dispute in the ordinary sense. Stefano Pessina, the executive chair of Walgreens Boots Alliance who is understood to now hold a stake approaching 50 percent in Boots, is reportedly unwilling to accept the Westons' lower valuation, giving one shareholder effective veto power over whether the sale proceeds at all. Pessina has lived in Monaco for years, one of a small number of European business figures whose personal address and whose company's fate are followed with roughly equal interest in the principality.
If the talks collapse entirely, Boots' owners have a fallback already sketched out: abandoning the sale process in favour of restructuring the business ahead of a London stock market listing within the next two years, a float that would be led by incoming chief executive Alex Baldock, arriving from Currys this autumn. A public listing would be a considerably slower route to a payout than a straight sale, but one that would not require Pessina's agreement on a price he has already signalled he finds too low.
None of this plays out in Monaco itself, a British pharmacy chain has no storefronts in the principality and the deal's mechanics run entirely through London and the Westons' own holding companies. What ties it back to Monaco is simply where its most consequential shareholder chooses to live, a reminder that a principality of forty thousand residents can still sit, quietly, at the centre of decisions affecting companies many times its own size.